Prognostic impact of conventional cytogenetics in acute myeloid leukemia treated with venetoclax and decitabine

被引：4

作者：

Venugopal, Sangeetha ^{[1
]}

Maiti, Abhishek ^{[1
]}

DiNardo, Courtney D. ^{[1
]}

Qiao, Wei ^{[2
]}

Ning, Jing ^{[2
]}

Loghavi, Sanam ^{[3
]}

Daver, Naval G. ^{[1
]}

Kadia, Tapan M. ^{[1
]}

Rausch, Caitlin R. ^{[4
]}

Alvarado, Yesid ^{[1
]}

Ohanian, Maro ^{[1
]}

Sasaki, Koji ^{[1
]}

Short, Nicholas J. ^{[1
]}

Takahashi, Koichi ^{[1
]}

Yilmaz, Musa ^{[1
]}

Ravandi, Farhad ^{[1
]}

Kantarjian, Hagop M. ^{[1
]}

Konopleva, Marina Y. ^{[1
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1400 Holcombe Blvd,Unit 428, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Pharm, Houston, TX 77030 USA

来源：

LEUKEMIA & LYMPHOMA | 2021年 / 62卷 / 14期

基金：

美国国家卫生研究院;

关键词：

AML; RECOMMENDATIONS; AZACITIDINE; DIAGNOSIS; SURVIVAL;

D O I：

10.1080/10428194.2021.1973675

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3501 / 3505

页数：5

共 13 条

[1] Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461) [J].

Byrd, JC ;

Mrózek, K ;

Dodge, RK ;

Carroll, AJ ;

Edwards, CG ;

Arthur, DC ;

Pettenati, MJ ;

Patil, SR ;

Rao, KW ;

Watson, MS ;

Koduru, PRK ;

Moore, JO ;

Stone, RM ;

Mayer, RJ ;

Feldman, EJ ;

Davey, FR ;

Schiffer, CA ;

Larson, RA ;

Bloomfield, CD .

BLOOD, 2002, 100 (13) :4325-4336

[2] Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia [J].

Cheson, BD ;

Bennett, JM ;

Kopecky, KJ ;

Büchner, T ;

Willman, CL ;

Estey, EH ;

Schiffer, CA ;

Döhner, H ;

Tallman, MS ;

Lister, TA ;

LoCocco, F ;

Willemze, R ;

Biondi, A ;

Hiddemann, W ;

Larson, RA ;

Löwenberg, B ;

Sanz, MA ;

Head, DR ;

Ohno, R ;

Bloomfield, CD .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (24) :4642-4649

[3] Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia [J].

DiNardo, C. D. ;

Jonas, B. A. ;

Pullarkat, V. ;

Thirman, M. J. ;

Garcia, J. S. ;

Wei, A. H. ;

Konopleva, M. ;

Doehner, H. ;

Letai, A. ;

Fenaux, P. ;

Koller, E. ;

Havelange, V. ;

Leber, B. ;

Esteve, J. ;

Wang, J. ;

Pejsa, V. ;

Hajek, R. ;

Porkka, K. ;

Illes, A. ;

Lavie, D. ;

Lemoli, R. M. ;

Yamamoto, K. ;

Yoon, S. -S. ;

Jang, J. -H. ;

Yeh, S. -P. ;

Turgut, M. ;

Hong, W. -J. ;

Zhou, Y. ;

Potluri, J. ;

Pratz, K. W. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (07) :617-629

[4] 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial [J].

DiNardo, Courtney D. ;

Maiti, Abhishek ;

Rausch, Caitlin R. ;

Pemmaraju, Naveen ;

Naqvi, Kiran ;

Daver, Naval G. ;

Kadia, Tapan M. ;

Borthakur, Gautam ;

Ohanian, Maro ;

Alvarado, Yesid ;

Issa, Ghayas C. ;

Montalban-Bravo, Guillermo ;

Short, Nicholas J. ;

Yilmaz, Musa ;

Bose, Prithviraj ;

Jabbour, Elias J. ;

Takahashi, Koichi ;

Burger, Jan A. ;

Garcia-Manero, Guillermo ;

Jain, Nitin ;

Kornblau, Steven M. ;

Thompson, Philip A. ;

Estrov, Zeev ;

Masarova, Lucia ;

Sasaki, Koji ;

Verstovsek, Srdan ;

Ferrajoli, Alessandra ;

Weirda, William G. ;

Wang, Sa A. ;

Konoplev, Sergej ;

Chen, Zhining ;

Pierce, Sherry A. ;

Ning, Jing ;

Qiao, Wei ;

Ravandi, Farhad ;

Andreeff, Michael ;

Welch, John S. ;

Kantarjian, Hagop M. ;

Konopleva, Marina Y. .

LANCET HAEMATOLOGY, 2020, 7 (10) :E724-E736

[5] Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care [J].

Doehner, Hartmut ;

Dolnik, Anna ;

Tang, Lin ;

Seymour, John F. ;

Minden, Mark D. ;

Stone, Richard M. ;

Bernal del Castillo, Teresa ;

Al-Ali, Haifa Kathrin ;

Santini, Valeria ;

Vyas, Paresh ;

Beach, C. L. ;

MacBeth, Kyle J. ;

Skikne, Barry S. ;

Songer, Steve ;

Tu, Nora ;

Bullinger, Lars ;

Dombret, Herve .

LEUKEMIA, 2018, 32 (12) :2546-2557

[6] Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].

Doehner, Hartmut ;

Estey, Elihu ;

Grimwade, David ;

Amadori, Sergio ;

Appelbaum, Frederick R. ;

Buechner, Thomas ;

Dombret, Herve ;

Ebert, Benjamin L. ;

Fenaux, Pierre ;

Larson, Richard A. ;

Levine, Ross L. ;

Lo-Coco, Francesco ;

Naoe, Tomoki ;

Niederwieser, Dietger ;

Ossenkoppele, Gert J. ;

Sanz, Miguel ;

Sierra, Jorge ;

Tallman, Martin S. ;

Tien, Hwei-Fang ;

Wei, Andrew H. ;

Lowenberg, Bob ;

Bloomfield, Clara D. .

BLOOD, 2017, 129 (04) :424-447

[7] The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1,612 patients entered into the MRC AML 10 trial [J].

Grimwade, D ;

Walker, H ;

Oliver, F ;

Wheatley, K ;

Harrison, C ;

Harrison, G ;

Rees, J ;

Hann, I ;

Stevens, R ;

Burnett, A ;

Goldstone, A .

BLOOD, 1998, 92 (07) :2322-2333

[8] Azacitidine for the treatment of relapsed and refractory AML in older patients [J].

Itzykson, Raphael ;

Thepot, Sylvain ;

Berthon, Celine ;

Delaunay, Jacques ;

Bouscary, Didier ;

Cluzeau, Thomas ;

Turlure, Pascal ;

Prebet, Thomas ;

Dartigeas, Caroline ;

Marolleau, Jean-Pierre ;

Recher, Christian ;

Plantier, Isabelle ;

Stamatoullas, Aspasia ;

Devidas, Alain ;

Taksin, Anne-Laure ;

Guieze, Romain ;

Caillot, Denis ;

Vey, Norbert ;

Ades, Lionel ;

Ifrah, Norbert ;

Dombret, Herve ;

Fenaux, Pierre ;

Gardin, Claude .

LEUKEMIA RESEARCH, 2015, 39 (02) :124-130

[9] Ten-Day Decitabine with Venetoclax Versus Intensive Chemotherapy in Relapsed or Refractory Acute Myeloid Leukemia: A Propensity Score Matched Analysis [J].

Maiti, Abhishek ;

DiNardo, Courtney D. ;

Kadia, Tapan M. ;

Jabbour, Elias ;

Rausch, Caitlin R. ;

Daver, Naval ;

Borthakur, Gautam ;

Pemmaraju, Naveen ;

Short, Nicholas J. ;

Yilmaz, Musa ;

Alvarado, Yesid ;

Montalbano, Kathryn S. ;

Wade, Allison ;

Maduike, Rita ;

Guerrero, Julio A. ;

Vaughan, Kenneth ;

Bivins, Carol A. ;

Pierce, Sherry A. ;

Ravandi, Farhad ;

Kantarjian, Hagop M. ;

Konopleva, Marina .

BLOOD, 2020, 136

[10] Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment-related mortality [J].

Maiti, Abhishek ;

Qiao, Wei ;

Sasaki, Koji ;

Ravandi, Farhad ;

Kadia, Tapan M. ;

Jabbour, Elias J. ;

Daver, Naval G. ;

Borthakur, Gautam ;

Garcia-Manero, Guillermo ;

Pierce, Sherry A. ;

Montalbano, Kathryn S. ;

Pemmaraju, Naveen ;

Naqvi, Kiran ;

Ohanian, Maro ;

Short, Nicholas J. ;

Alvarado, Yesid ;

Takahashi, Koichi ;

Yilmaz, Musa ;

Jain, Nitin ;

Kornblau, Steven M. ;

Andreeff, Michael ;

Bose, Prithviraj ;

Ferrajoli, Alessandra ;

Issa, Ghayas C. ;

Masarova, Lucia ;

Thompson, Philip A. ;

Rausch, Caitlin R. ;

Ning, Jing ;

Kantarjian, Hagop M. ;

DiNardo, Courtney D. ;

Konopleva, Marina Y. .

AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (03) :282-291

← 1 2 →